ASLAN Pharmaceuticals Ltd (ASLN)
0.4449
+0.01
(+2.25%)
USD |
NASDAQ |
May 17, 16:00
0.4449
0.00 (0.00%)
After-Hours: 20:00
ASLAN Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 12.00M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 3.00M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.9617M |
| September 30, 2016 | 10.32M |
| June 30, 2016 | 0.2539M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
12.00M
Minimum
Jun 2023
12.00M
Maximum
Jun 2023
12.00M
Average
12.00M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 852.90M |
| Concord Medical Services Holdings Ltd | -- |
| Zai Lab Ltd | 87.15M |
| WAVE Life Sciences Ltd | 12.54M |
| CytoMed Therapeutics Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.920M |
| Total Expenses (Quarterly) | 9.291M |
| EPS Diluted (Quarterly) | -0.50 |
| Enterprise Value | 18.16M |
| Earnings Yield | -420.3% |
| Normalized Earnings Yield | -701.98 |